Schedule 13D ownership disclosure

OPIANT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 683750103

Event date: 2018-10-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001385508-20-000023
Form type
SC 13D/A
Filer
OPIANT PHARMACEUTICALS, INC.
CIK
CIK 1385508
Filed
Feb 06, 2020
Reporting period
Oct 09, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub